Zsotér T T, Nebitko R L, Chow R
Department of Pharmacology, University of Toronto, Ontario, Canada.
Clin Invest Med. 1988 Dec;11(6):430-4.
Heart rate in nifedipine treated patients tends to be higher than in those treated with verapamil or diltiazem. This may be due, among other causes, to a differential action on cardiac baroreflexes. As conclusions of previous studies were controversial, we decided to study the effect of verapamil, diltiazem and nifedipine on baroreflex sensitivity. After 3-5 week treatment, heart rate response to various doses of i.v. phenylephrine and sodium nitroprusside was recorded in conscious rats. The slope of the regression line relating change of heart rate to change in blood pressure, was depressed in verapamil treated rats compared to that in control, diltiazem or nifedipine treated rats (p less than 0.0001). The role of the autonomic nervous system in modulation of baroreflexes was investigated by pretreatment of the animals with propranolol or atropine. The results were compatible with the hypothesis that verapamil depresses adrenergic nerve activity and this may contribute to decreased, vasodilation-induced baroreceptor reflexes.
硝苯地平治疗的患者心率往往高于维拉帕米或地尔硫䓬治疗的患者。这可能是由于,除其他原因外,对心脏压力反射的不同作用。由于先前研究的结论存在争议,我们决定研究维拉帕米、地尔硫䓬和硝苯地平对压力反射敏感性的影响。在3 - 5周的治疗后,记录清醒大鼠对不同剂量静脉注射去氧肾上腺素和硝普钠的心率反应。与对照组、地尔硫䓬或硝苯地平治疗的大鼠相比,维拉帕米治疗的大鼠中,心率变化与血压变化相关的回归线斜率降低(p小于0.0001)。通过用普萘洛尔或阿托品对动物进行预处理,研究了自主神经系统在调节压力反射中的作用。结果与以下假设一致,即维拉帕米抑制肾上腺素能神经活动,这可能导致血管舒张诱导的压力感受器反射降低。